Exchange: NYSEArca·Updated 07:54 PM EDT
LLYX logo

LLYXDefiance Daily Target 2X Long LLY ETF

$28.21
$0.86
(3.14%)
Today
Closed $28.21
$0.0891
(0.32%)
After Hours
Vol530,971.00
52W High$29.52
52W Low$9.60
News
all
press releases
News Placeholder
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.